4//SEC Filing
Cranston Lynda Sarah 4
Accession 0001213900-18-013296
CIK 0001498382other
Filed
Sep 30, 8:00 PM ET
Accepted
Oct 1, 4:07 PM ET
Size
4.9 KB
Accession
0001213900-18-013296
Insider Transaction Report
Form 4
Cranston Lynda Sarah
Director
Transactions
- Other
Common Stock
2018-09-28$3.20/sh+71$227→ 2,770 total(indirect: Held by J.G. Cranston & Associates, Inc.)
Footnotes (1)
- [F1]The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock.
Documents
Issuer
DelMar Pharmaceuticals, Inc.
CIK 0001498382
Entity typeother
Related Parties
1- filerCIK 0001633660
Filing Metadata
- Form type
- 4
- Filed
- Sep 30, 8:00 PM ET
- Accepted
- Oct 1, 4:07 PM ET
- Size
- 4.9 KB